
Approximately 100 abstracts featuring clonoSEQ® MRD testing will be presented at #ASH26, highlighting its central role in advancing MRD assessment across hematology—from evaluating treatment response to informing treatment strategies and patient care. adaptivebio.tech/67a058

















